NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,373,197 | +572.8% | 14,351,000 | +474.0% | 0.02% | +633.3% |
| Q2 2023 | $3,176,523 | -5.9% | 2,500,000 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $3,376,802 | -14.9% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,970,192 | +12.2% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,540,000 | +7.0% | 2,500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,308,000 | -93.5% | 2,500,000 | -93.5% | 0.00% | -91.7% |
| Q1 2022 | $50,796,000 | +4.8% | 38,635,000 | 0.0% | 0.05% | +20.0% |
| Q4 2021 | $48,457,000 | -6.1% | 38,635,000 | 0.0% | 0.04% | -14.9% |
| Q3 2021 | $51,580,000 | -0.9% | 38,635,000 | -1.6% | 0.05% | +4.4% |
| Q2 2021 | $52,046,000 | +667.0% | 39,270,000 | +685.4% | 0.04% | +542.9% |
| Q1 2021 | $6,786,000 | -50.8% | 5,000,000 | -50.0% | 0.01% | -50.0% |
| Q3 2020 | $13,805,000 | – | 10,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |